NCT03844750 2025-12-31
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases
University of California, San Francisco
Phase 2 Terminated
University of California, San Francisco
Oslo University Hospital
Azienda Ospedaliero Universitaria Maggiore della Carita
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Hamilton Health Sciences Corporation
Humanitas Clinical and Research Center
Azienda Ospedaliera San Giovanni Battista
University Hospital, Ghent